Successful Use of Dupilumab in Bullous Pemphigoid: A Series of 3 Cases in Mexico

This review explores three recent case reports detailing the successful treatment of bullous pemphigoid (BP) with Dupilumab, a monoclonal antibody targeting interleukin-4 receptor alpha subunit (IL-4Rα). Each case highlights unique clinical presentations, treatment approaches, and outcomes, underscoring Dupilumab's potential as a therapeutic option in BP management.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-01
DOI
https://doi.org/10.5281/zenodo.14958235
Primary Topic
Effects of Radiation Exposure
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful Use of Dupilumab in Bullous Pemphigoid: A Series of 3 Cases in Mexico

Zenodo (CERN European Organization for Nuclear Research)
Effects of Radiation Exposure
article

Successful Use of Dupilumab in Bullous Pemphigoid: A Series of 3 Cases in Mexico

article en

Abstract

This review explores three recent case reports detailing the successful treatment of bullous pemphigoid (BP) with Dupilumab, a monoclonal antibody targeting interleukin-4 receptor alpha subunit (IL-4Rα). Each case highlights unique clinical presentations, treatment approaches, and outcomes, underscoring Dupilumab's potential as a therapeutic option in BP management.

Zenodo (CERN European Organization for Nuclear Research)
Universidad Nacional Autónoma de México (MX)
Good health and well-being
Openalex Percentile: Top 40%
Effects of Radiation Exposure
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Successful Use of Dupilumab in Bullous Pemphigoid: A Series of 3 Cases in Mexico · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS